EUVIMEDEUVIMED entdecken
Crossref

Irisin, a new envoy in newly diagnosed type 2 diabetes mellitus – A plausible association with insulin resistance

Saffalya Nayak, Debjyoti Mohapatra

Journal of Clinical and Basic Research · 2022

DOI: 10.61186/jcbr.6.4.19 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Basic Research, 2022. Verfasst von Saffalya Nayak und 1 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Nayak, S., & Mohapatra, D. (2022). Irisin, a new envoy in newly diagnosed type 2 diabetes mellitus – A plausible association with insulin resistance. Journal of Clinical and Basic Research. https://doi.org/10.61186/jcbr.6.4.19

Vancouver

Nayak S, Mohapatra D. Irisin, a new envoy in newly diagnosed type 2 diabetes mellitus – A plausible association with insulin resistance. Journal of Clinical and Basic Research. 2022. doi:10.61186/jcbr.6.4.19

BibTeX
@article{Nayak2022,
  author = {Nayak, Saffalya and Mohapatra, Debjyoti},
  title = {Irisin, a new envoy in newly diagnosed type 2 diabetes mellitus – A plausible association with insulin resistance},
  journal = {Journal of Clinical and Basic Research},
  year = {2022},
  doi = {10.61186/jcbr.6.4.19}
}
Kostenlos starten →